Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide, said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development, at Novo Nordisk
If your hair loss is tied to how fast you are losing weight, adjusting your plan may help your hair follicles recover faster
If a patient smokes while taking semaglutide, their risk of experiencing chest pain can increase significantly
Call-On-Doc is Americas highest-rated telemedicine provider, with over two million active patients and more than 406,000 five-star reviews
He provides physician-guided GLP-1 treatments, bariatric care, and personalized weight loss programs
Pillemer, J.P